Peroxisome proliferator-activated receptor α protects against alcohol-induced liver damage

被引:187
|
作者
Nakajima, T
Kamijo, Y
Tanaka, N [1 ]
Sugiyama, E
Tanaka, E
Kiyosawa, K
Fukushima, Y
Peters, JM
Gonzalez, FJ
Aoyama, T
机构
[1] Shinshu Univ, Grad Sch Med, Inst Aging & Adaptat, Dept Metab Regulat, Matsumoto, Nagano 3908621, Japan
[2] Shinshu Univ, Sch Med, Dept Hyg & Med Genet, Matsumoto, Nagano 3908621, Japan
[3] Nagoya Univ, Grad Sch Med, Dept Environm & Occupat Hlth, Nagoya, Aichi, Japan
[4] Shinshu Univ, Sch Med, Dept Internal Med, Matsumoto, Nagano 3908621, Japan
[5] Nagano Prefectural Coll, Course Sci Living, Nagano, Japan
[6] Penn State Univ, Ctr Mol Toxicol & Carcinogenesis, Dept Vet Sci, University Pk, PA 16802 USA
[7] NCI, Lab Metab, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.1002/hep.20399
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The mechanisms underlying alcoholic liver disease are not completely understood, but lipid accumulation seems to be central to the cause of this disease. The peroxisome proliferator-activated receptor alpha (PPARalpha) plays an important role in the control of lipid homeostasis, metabolism of bioactive molecules, and modulation of inflammatory responses. To investigate the roles of PPARaalpha in alcoholic liver injury, wild-type and PPARalpha-null mice were continuously fed a diet containing 4% ethanol, and liver injury was analyzed. PPARalpha-null mice fed ethanol exhibited marked hepatomegaly, hepatic inflammation, cell toxicity, fibrosis, apoptosis, and mitochondrial swelling. Some of these hepatic abnormalities were consistent with those of patients with alcoholic liver injury and were not found in wild-type mice. Next, the molecular mechanisms of ethanol-induced liver injury in PPARalpha-null mice were investigated, and changes related to ethanol and acetaldehyde metabolism, oxidative stress, inflammation, hepatocyte proliferation, fibrosis, and mitochondrial permeability transition activation occurred specifically in PPARalpha-null mice as compared with wild-type mice. In conclusion, these studies suggest a protective role for PPARalpha in alcoholic liver disease. Humans may be more susceptible to liver toxicity induced by ethanol as PPARalpha expression in human liver is considerably lower compared to that of rodents.
引用
收藏
页码:972 / 980
页数:9
相关论文
共 50 条
  • [21] The Peroxisome Proliferator-Activated Receptor α (PPARα) Agonist Pemafibrate Protects against Diet-Induced Obesity in Mice
    Araki, Masaya
    Nakagawa, Yoshimi
    Oishi, Asayo
    Han, Song-iee
    Wang, Yunong
    Kumagai, Kae
    Ohno, Hiroshi
    Mizunoe, Yuhei
    Iwasaki, Hitoshi
    Sekiya, Motohiro
    Matsuzaka, Takashi
    Shimano, Hitoshi
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (07)
  • [22] Modulation of Fatty Acid and Bile Acid Metabolism By Peroxisome Proliferator-Activated Receptor Protects Against Alcoholic Liver Disease
    Li, Heng-Hong
    Tyburski, John B.
    Wang, Yi-Wen
    Strawn, Steve
    Moon, Bo-Hyun
    Kallakury, Bhaskar V. S.
    Gonzalez, Frank J.
    Fornace, Albert J.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2014, 38 (06) : 1520 - 1531
  • [23] Peroxisome proliferator-activated receptor-γ protects against hepatic ischemia/reperfusion injury in mice
    Kuboki, Satoshi
    Shin, Thomas
    Huber, Nadine
    Eismann, Thorsten
    Galloway, Elizabeth
    Schuster, Rebecca
    Blanchard, John
    Zingarelli, Basifia
    Lentsch, Alex B.
    HEPATOLOGY, 2008, 47 (01) : 215 - 224
  • [24] Peroxisome proliferator-activated receptor-γ agonist troglitazone protects against nondiabetic glomerulosclerosis in rats
    Ma, LJ
    Marcantoni, C
    Linton, MF
    Fazio, S
    Fogo, AB
    KIDNEY INTERNATIONAL, 2001, 59 (05) : 1899 - 1910
  • [25] The Agonists of Peroxisome Proliferator-Activated Receptor-γ for Liver Fibrosis
    Li, Jingjing
    Guo, Chuanyong
    Wu, Jianye
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2021, 15 : 2619 - 2628
  • [26] Peroxisome proliferator-activated receptor γ and atherosclerosis
    Marx, N
    CURRENT HYPERTENSION REPORTS, 2002, 4 (01) : 71 - 77
  • [27] Peroxisome proliferator-activated receptor agonists
    Willson, TM
    Wahli, W
    CURRENT OPINION IN CHEMICAL BIOLOGY, 1997, 1 (02) : 235 - 241
  • [28] Regulation of peroxisome proliferator-activated receptor-γ in liver fibrosis
    Yang, Liu
    Chan, Che-Chang
    Kwon, Oh-Sang
    Liu, Songling
    McGhee, Jason
    Stimpson, Stephen A.
    Chen, Lihong Z.
    Harrington, W. Wallace
    Symonds, William T.
    Rockey, Don C.
    AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2006, 291 (05): : G902 - G911
  • [29] Peroxisome proliferator-activated receptor γ and cancers
    Koeffler, HP
    CLINICAL CANCER RESEARCH, 2003, 9 (01) : 1 - 9
  • [30] Chondrosarcoma and Peroxisome Proliferator-Activated Receptor
    Nishida, K.
    Kunisada, T.
    Shen, Z. N.
    Kadota, Y.
    Hashizume, K.
    Ozaki, T.
    PPAR RESEARCH, 2008, 2008